06 October 2020
Back in June 2020 we published the MTPConnect COVID-19 Impact Report, which revealed the COVID-19 health crisis had a significant negative impact across the medical technology, biotechnology and pharmaceutical (MTP) sector, including startups, SMEs, large local and multinational companies, researchers, universities, service providers, industry organisations and investors.
Our research covered the four-month period up to May 2020.
As promised, we have updated this report in partnership with L.E.K. Consulting, researching the COVID-19 response and recovery efforts undertaken by the sector during June to September 2020.
The second edition of the MTPConnect COVID-19 Impact Report is now available. It includes perspectives shared by senior stakeholders from industry associations, companies, regulatory bodies, research organisations, government representatives and funders. This feedback has informed key insights, case studies and recommendations within this report.
The Report’s second edition is a valuable resource outlining six key issues that must be addressed for the sector’s recovery, six trends that present opportunities for growth and actions that can be taken to better prepare for future pandemics.
Australia is in the midst of a significant recession and the journey to recovery will take time. The MTP sector faces a number of key challenges in the near term and we will continue to work with industry participants and government to ensure the sector remains at the forefront of delivering innovative health solutions and restoring jobs and economic growth to Australia.
Thanks to all those from the sector who shared their time and insights through the online survey and stakeholder consultations.
Take a read and let us know your feedback.